iSERA Lifesciences Closes Trading Window for Q1 FY27 Results

iSERA Lifesciences Ltd has announced the closure of its trading window for designated persons and their immediate relatives. This closure is in compliance with SEBI regulations and the company's code of conduct. The window will be shut from July 01, 2026, until 48 hours after the announcement of the Un-Audited Financial Results for the Quarter ended June 30, 2026. The exact date of the board meeting to approve these results will be communicated later. This measure is standard practice to prevent insider trading during sensitive financial reporting periods.